Oppenheimer Holdings Stock News

Oppenheimer lowers its price target on Outperform-rated Vector Group (VGR) to $13.50 to account for the completed spin-off of Douglas Elliman on December 30. Read more.

The market did not seem very pleased with Plug Powers (PLUG) latest business update. Shares took the down escalator after the company reiterated its 2022 revenue g

Record earnings in 9M 2021.

Six Flags Entertainment (SIX) is on watch after Oppenheimer turns constructive with an upgrade to an Outperform rating from Peer Perform

Qorvo (QRVO) is getting slapped with a downgrade from Oppenheimer, as the investment firm notes the semiconductor company has realized the gains from 5G as fast as it thought it would

Oppenheimer starts off coverage on Hertz Global Holdings (HTZ) with an Outperform rating on a positive post-bankruptcy view of the upside for the car rental company. Read more.

Starbucks lagged the broader market in 2021 and could struggle to rise in 2022, according to RBC and Oppenheimer.

SPX Co. (NYSE:SPXC) Equities research analysts at Oppenheimer boosted their FY2022 earnings estimates for shares of SPX in a research report issued on Monday, December 20th. Oppenheimer analyst B. Blair now anticipates that the company will post earnings of $2.95 per share for the year, up from their previous forecast of $2.90. Oppenheimer also []

41246 (APO.V) (CVE:APO) Equities research analysts at Oppenheimer issued their Q3 2022 earnings per share estimates for shares of 41246 (APO.V) in a report issued on Tuesday, December 21st. Oppenheimer analyst L. Gershell forecasts that the company will post earnings of ($0.10) per share for the quarter. Oppenheimer also issued estimates for 41246 (APO.V)s []

Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Investment analysts at Oppenheimer reduced their FY2021 earnings per share (EPS) estimates for Aldeyra Therapeutics in a report released on Monday, December 20th. Oppenheimer analyst J. Kim now anticipates that the biotechnology company will earn ($1.11) per share for the year, down from their previous forecast of ($1.09). Oppenheimer also []

HHM Wealth Advisors LLC acquired a new position in Vanguard Financials ETF (NYSEARCA:VFH) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 2,000 shares of the companys stock, valued at approximately $185,000. Several other institutional investors also recently bought and sold shares of VFH. Oppenheimer []

Amgen Inc. (NASDAQ:AMGN) Investment analysts at Oppenheimer boosted their FY2025 earnings per share estimates for Amgen in a research report issued to clients and investors on Monday, December 20th. Oppenheimer analyst J. Olson now forecasts that the medical research company will post earnings per share of $23.19 for the year, up from their prior []

Morgan Stanley (NYSE:MS) Equities research analysts at Oppenheimer lifted their Q1 2022 earnings estimates for Morgan Stanley in a report issued on Wednesday, December 22nd. Oppenheimer analyst C. Kotowski now anticipates that the financial services provider will post earnings of $1.95 per share for the quarter, up from their previous estimate of $1.93. Oppenheimer []

Littelfuse, Inc. (NASDAQ:LFUS) Equities research analysts at Oppenheimer cut their Q1 2022 EPS estimates for Littelfuse in a report released on Tuesday, December 21st. Oppenheimer analyst C. Glynn now anticipates that the technology company will earn $2.89 per share for the quarter, down from their prior estimate of $2.96. Oppenheimer also issued estimates for []